BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.72
-2.70%
After-hours: Aug 15, 2025, 07:39 PM EDT
BriaCell Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
August - July.
Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 |
Cash & Equivalents | 12.46M | 5.01M | 5.79M | 862.09K | 935.69K | 6.24M | 13.65M | 21.25M | 28.17M | 33.5M | 37.45M | 41.04M | 44.53M | 47.98M | 55.49M | 57.27M | 20.08M | 5.72K | 6.45K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 496.65K | 454.39K | 421.98K | 418.49K | 469.66K | 281.66K | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.63 | 1.56 | 1.50 |
Other Long-Term Assets | 1.21M | 1.21M | 1.21M | 1.21M | n/a | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | n/a | n/a | n/a | -0.63 | 0.44 | -0.5 |
Receivables | 2.32M | 2.15M | 2.43M | 1.37M | 15.23K | 30.14K | 21.41K | 717.74K | 14.9K | 8.93K | 29.7K | 24.1K | 14.53K | 27.17K | 19.33K | 12.57K | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | -1.71M | 5.46M | 4.73M | 5.67M | 1.32M | 428.81K | n/a | n/a | n/a | -83.41K | -97.44K | n/a | -160.82K | -56.7K | -67.54K |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 867.02K | n/a | n/a |
Total Current Assets | 14.79M | 7.16M | 8.22M | 3.65M | 5.53M | 11.74M | 18.41M | 26.95M | 29.5M | 33.94M | 38.22M | 42.35M | 46.23M | 48.32M | 55.92M | 57.8M | 20.8M | 214.09K | 215.86K |
Property-Plant & Equipment | 319.66K | 342.5K | 365.34K | 388.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 188.34K | 192.16K | 195.98K | 199.8K | 203.61K | 207.43K | 211.25K | 215.07K | 218.89K | 222.7K | 226.52K | 230.34K | 234.16K | 237.97K | 241.79K | 245.61K | 249.58K | 243.37K | 237.03K |
Total Long-Term Assets | 2.22M | 2.2M | 2.2M | 2.22M | 673.27K | 489.09K | 211.25K | 215.07K | 218.89K | 222.71K | 226.52K | 230.34K | 234.16K | 237.98K | 241.79K | 245.61K | 249.58K | 243.37K | 237.04K |
Total Assets | 17M | 9.36M | 10.41M | 5.87M | 6.2M | 12.23M | 18.62M | 27.16M | 29.72M | 34.16M | 38.45M | 42.58M | 46.46M | 48.55M | 56.16M | 58.04M | 21.05M | 457.46K | 452.89K |
Account Payables | 3.28M | 5M | 4.23M | 7.17M | 6.42M | 3.71M | 433.92K | 1.12M | 995.25K | 582.45K | 791.75K | 463.28K | 330.61 | n/a | 240.05K | 214.12K | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 386.56K | 258.76K |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 406.31K | n/a | n/a | n/a | n/a | n/a | 365.96K | 605.15K | 191.31K | n/a | 169.87K | 3.55M | 3.42M |
Total Current Liabilities | 4.33M | 5.23M | 4.99M | 7.46M | 6.76M | 3.92M | 1.05M | 1.8M | 1.38M | 670.41K | 974.05K | 941.09K | 366.29K | 605.15K | 431.37K | 556.79K | 169.87K | 3.94M | 3.68M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.96K | 25.99K | n/a | n/a | n/a |
Other Long-Term Liabilities | 730.01K | 905.84K | 1.71M | 1.1M | 5.68M | 16.62M | 15.06M | 29.14M | 34.23M | 34.77M | 27.14M | 31.31M | 278.4K | 248.49K | 306.22K | 199.46K | 6.9M | n/a | n/a |
Total Long-Term Liabilities | 730.01K | 905.84K | 1.71M | 1.1M | 5.68M | 16.62M | 15.06M | 29.14M | 34.23M | 34.77M | 27.14M | 31.31M | 278.4K | 248.49K | 333.19K | 225.44K | 7.06M | 149.65K | 144.3K |
Total Liabilities | 5.06M | 6.14M | 6.7M | 8.56M | 12.44M | 20.55M | 16.1M | 30.94M | 35.61M | 35.44M | 28.12M | 32.25M | 644.69K | 853.64K | 764.55K | 782.24K | 7.23M | 4.09M | 3.82M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.96K | 25.99K | n/a | 386.56K | 258.76K |
Common Stock | 94.02M | 85.15M | 82.04M | 72.17M | 69.59M | 69.59M | 69.59M | 69.59M | 65.59M | 65.59M | 65.59M | 65.59M | 55.85M | 53.94M | 55.36M | 54.78M | 25.29M | 12.13M | 11.59M |
Retained Earnings | -103.66M | -97.54M | -91.25M | -85.44M | -84.23M | -85.95M | -74.65M | -80.65M | -78.23M | -73.34M | -61.46M | -60.35M | -27.58M | -22.76M | -18.14M | -15.75M | -14.01M | -18.11M | -17.12M |
Comprehensive Income | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -138.68K | -85.5K | 28.97K | -95.3K |
Shareholders Equity | 12.42M | 3.6M | 4.04M | -2.38M | -5.97M | -8.07M | 2.72M | -3.78M | -5.89M | -1.28M | 10.33M | 10.33M | 45.82M | 47.7M | 55.39M | 57.26M | 13.82M | -3.63M | -3.37M |
Total Investments | 496.65K | 454.39K | 421.98K | 418.49K | 469.66K | 281.66K | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.63 | 1.56 | 1.50 |